This paper is in the following e-collection/theme issue:

Cancer Survivorship (353) Innovations and Technology in Cancer Care (557) Artificial Intelligence (2252) Participatory Medicine & E-Patients (890) Cancer Self-Management (97) Chatbots and Conversational Agents (767)

Published on in Vol 11 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/77390, first published .
Evaluation of Cancer Survivors’ Experience of Using AI-Based Conversational Tools: Qualitative Study

Evaluation of Cancer Survivors’ Experience of Using AI-Based Conversational Tools: Qualitative Study

Evaluation of Cancer Survivors’ Experience of Using AI-Based Conversational Tools: Qualitative Study

Authors of this article:

Saif Khairat1, 2, 3 Author Orcid Image ;   Hanna Mehraby1, 2 Author Orcid Image ;   Safoora Masoumi1 Author Orcid Image ;   Melissa Coffel2 Author Orcid Image ;   Callie Rockey-Bartlett2, 4 Author Orcid Image ;   Andrea Huang2, 4 Author Orcid Image ;   William Wood3 Author Orcid Image ;   Ethan Basch3 Author Orcid Image
Article Authors Cited by (1) Tweetations (1) Metrics

Journals

  1. Cui S, Wang S, Deng J, Jia R, Jiang Y. Facilitators and Barriers of Using an Artificial Intelligence Agent in Chronic Disease Management: A Normalization Process Theory-Guided Qualitative Study of Older Patients with COPD. Healthcare 2026;14(2):268 View